← Holders
Euclidean Capital LLC
What Euclidean Capital LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1825034 · Filed Nov 16, 2026
- Positions
- 10
- Reported value
- $323.6M
- Opened
- 1
- Closed
- 2
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$238M11 positions
- Dec 31, 2025$369.5M12 positions
- Mar 31, 2026$392.3M10 positions
- Jun 30, 2026$439.8M11 positions
- Sep 30, 2026$323.6M10 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
VANGUARD INTL EQUITY INDEX FALLWRLD EX US | 3.2M | ±0% | $269.1M | 83.2% |
ISHARES TRMSCI INDIA ETF | 369.6K | ±0% | $17.3M | 5.3% |
ORICOric Pharmaceuticals, Inc. | 989.4K | ±0% | $13.3M | 4.1% |
TMSTeamshares Inc | 1.1M | ±0% | $8M | 2.5% |
FHTXFoghorn Therapeutics Inc. | 1.6M | ±0% | $5.6M | 1.7% |
PMVPPMV Pharmaceuticals, Inc. | 2.6M | ±0% | $4.4M | 1.4% |
SRZNSurrozen, Inc. | 87.7K | ±0% | $2.8M | 0.9% |
ALECAlector, Inc. | 1.3M | ±0% | $2.4M | 0.7% |
TNYATenaya Therapeutics, Inc. | 1M | ±0% | $613.1K | 0.2% |
MRLNMerlin, Inc. | 47.6K | New | $89.5K | 0.1% |